Reid von Borstel

Wellstat, Gaithersburg, MD, United States 
"Reid von Borstel"
Mean distance: 14.64 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Saydoff JA, Olariu A, Sheng J, et al. (2013) Uridine prodrug improves memory in Tg2576 and TAPP mice and reduces pathological factors associated with Alzheimer's disease in related models. Journal of Alzheimer's Disease : Jad. 36: 637-57
Jan Drake JW, von Borstel RW, Hennig UGG. (2012) In Memoriam R. C. (Jack) von Borstel (January 24, 1925-April 19, 2012) Environmental and Molecular Mutagenesis
Lo B, Swafford AD, Shafer-Weaver KA, et al. (2011) Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes status. Journal of Translational Medicine. 9: 203
Saydoff JA, Garcia RA, Browne SE, et al. (2006) Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease. Neurobiology of Disease. 24: 455-65
Saif MW, von Borstel R. (2006) 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice. Cancer Chemotherapy and Pharmacology. 58: 136-42
Garcia RA, Liu L, Hu Z, et al. (2005) Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine. Brain Research. 1066: 164-71
Klivenyi P, Gardian G, Calingasan NY, et al. (2004) Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity. Neuromolecular Medicine. 6: 87-92
Saydoff JA, Liu LS, Garcia RA, et al. (2003) Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. Brain Research. 994: 44-54
Barclay BJ, Dehaan CL, Hennig UGG, et al. (2001) Richard B. Setlow, a commentary on seminal contributions and scientific controversies Environmental and Molecular Mutagenesis. 38: 122-131
Caldwell SH, Hespenheide EE, von Borstel RW. (2001) Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin. Digestive Diseases and Sciences. 46: 376-8
See more...